Korean Stocks Hit Lowest Valuation Since 2008 Crisis Amid Chip Concerns

South Korean stocks saw valuations drop to their lowest level since the 2008 financial crisis following a two-week market correction, with the KOSPI forward price-to-earnings ratio falling below 7.0x for the first time in over a decade. The decline was driven by concerns over artificial intelligence demand uncertainty and memory chip upcycle peak-out noise, which pushed Samsung Electronics and SK Hynix down 8.8% and 9.3% respectively over the past week. Kiwoom Securities analyst Han Ji-young identified Samsung Electronics' preliminary earnings announcement on the 7th and SK Hynix's ADR listing on the 10th as key events that will determine near-term market direction.

Samsung Electronics and SK Hynix Events Set as Market Direction Factors

Kiwoom Securities analyst Han Ji-young stated on the 6th that Samsung Electronics' preliminary earnings announcement on the 7th and SK Hynix's ADR listing event on the 10th are the key factors that will influence market direction and volatility this week. Han noted that unlike past earnings announcements when expectations were high, this time both anticipation and anxiety coexist in the market. The analyst explained that setting a base scenario of relief across the broader market rather than a sell-on-news reaction after Samsung Electronics' preliminary results announcement would be appropriate.

KOSPI Forward P/E Falls Below 7.0x for First Time Since 2008 Crisis

The KOSPI forward price-to-earnings ratio fell below 7.0x for the first time since the 2008 financial crisis amid last week's market turmoil. Han assessed that the stock price correction over the past two weeks was excessive considering that no large-scale shock equivalent to the financial crisis has occurred. The analyst added that while volatility may temporarily increase as the market processes macro events including the Federal Reserve and semiconductor leading stock events, valuation-based perception of a bottom is expected to act as a factor enhancing recovery resilience across the KOSPI.

SK Hynix ADR Listing Involves 2.5% New Share Issuance

Regarding SK Hynix's ADR listing, the analyst observed that actual supply pressure will be limited because the new share issuance volume is only approximately 2.5% of total outstanding shares. Han stated that the key factor is whether the listing on the 10th will be successful in the US market, noting that depending on the results, a narrative could form to narrow the P/E gap with Micron, which receives a higher valuation premium at 6.7x compared to Samsung Electronics at 5.5x and SK Hynix at 6.2x in the US market. The analyst also noted that SK Hynix single-stock leverage trading volume has recently accounted for approximately 20% of KOSPI trading volume, which is a factor that could increase supply-demand volatility across the broader market, while emphasizing that the strengthened downside rigidity of the index should also be reflected in strategy.

FAQ

What caused Korean stocks to drop to their lowest valuation since 2008? Korean stocks experienced a two-week correction driven by concerns over artificial intelligence demand uncertainty and memory chip upcycle peak-out noise, causing the KOSPI forward P/E ratio to fall below 7.0x for the first time since the 2008 financial crisis. Samsung Electronics and SK Hynix declined 8.8% and 9.3% respectively over the past week.

What are the key events affecting Korean stock market direction this week? Kiwoom Securities identified Samsung Electronics' preliminary earnings announcement on the 7th and SK Hynix's ADR listing on the 10th as the key events that will influence market direction and volatility. The analyst noted that unlike past earnings announcements, this time both anticipation and anxiety coexist in the market.

Disclaimer: The information on this page may come from third-party sources and is for reference only. It does not represent the views or opinions of Gate and does not constitute any financial, investment, or legal advice. Virtual asset trading involves high risk. Please do not rely solely on the information on this page when making decisions. For details, see the Disclaimer.
Comment
0/400
No comments